CoChat

Adult Human Glia, Pericytes and Meningeal Fibroblasts Respond Similarly to IFNy but Not to TGFβ1 or M-CSF

Open access

The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.

Abstract

The chemokine Interferon gamma-induced protein 10 (IP-10) and human leukocyte antigen (HLA) are widely used indicators of glial activation and neuroinflammation and are up-regulated in many brain disorders. These inflammatory mediators have been widely studied in rodent models of brain disorders, but less work has been undertaken using human brain cells. In this study we investigate the regulation of HLA and IP-10, as well as other cytokines and chemokines, in microglia, astrocytes, pericytes, and meningeal fibroblasts derived from biopsy and autopsy adult human brain, using immunocytochemistry and a Cytometric Bead Array. Interferonγ (IFNγ) increased microglial HLA expression, but contrary to data in rodents, the anti-inflammatory cytokine transforming growth factor β1 (TGFβ1) did not inhibit this increase in HLA, nor did TGFβ1 affect basal microglial HLA expression or IFNγ-induced astrocytic HLA expression. In contrast, IFNγ-induced and basal microglial HLA expression, but not IFNγ-induced astrocytic HLA expression, were strongly inhibited by macrophage colony stimulating factor (M-CSF). IFNγ also strongly induced HLA expression in pericytes and meningeal fibroblasts, which do not basally express HLA, and this induction was completely blocked by TGFβ1, but not affected by M-CSF. In contrast, TGFβ1 did not block the IFNγ-induced increase in IP-10 in pericytes and meningeal fibroblasts. These results show that IFNγ, TGFβ1 and M-CSF have species- and cell type-specific effects on human brain cells that may have implications for their roles in adult human brain inflammation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0080463

Cites

91 of 91 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Microglial expression of HLA-DP, DQ, DR is increased by IFNy, not changed by TGFβ1, and reduced by M-CSF. A) Adult human PU.1+ve microglia (pink) express variable levels of HLA-DP, DQ, DR (green) in basal conditions without any treatment. All nuclei are labelled with Hoechst (blue). B) IFNy (1 ng/ml, 96 h) increased microglial expression of HLA-DP, DQ, DR, as well as HLA-DP, DQ, DR expression by astrocytes and pericytes in the mixed glial culture. C) TGFβ1 (10 ng/ml) did not affect microglial HLA-DP, DQ, DR expression alone, or when enhanced by IFNy treatment (D). E) M-CSF (25 ng/ml) reduced basal HLA-DP, DQ, DR expression in microglia and also decreased IFNy-enhanced HLA-DP, DQ, DR expression in microglia (F). Scale bar = 100 µm. G) A significant increase in percentage of HLA-positive microglia is found with IFNy treatment. No change in microglial HLA-DP, DQ, DR expression is seen for TGFβ1 treatment, but M-CSF significantly reduces microglial HLA-DP, DQ, DR protein expression (N = 12). H) The number of microglia per image, as measured by PU.1-immunopositive cells, is significantly increased by IFNy and M-CSF. However, TGFβ1 significantly reduces microglial cell number (N = 12).
Figure 1 Microglial expression of HLA-DP, DQ, DR is increased by IFNy, not changed by TGFβ1, and reduced by M-CSF. A) Adult human PU.1+ve microglia (pink) express variable levels of HLA-DP, DQ, DR (green) in basal conditions without any treatment. All nuclei are labelled with Hoechst (blue). B) IFNy (1 ng/ml, 96 h) increased microglial expression of HLA-DP, DQ, DR, as well as HLA-DP, DQ, DR expression by astrocytes and pericytes in the mixed glial culture. C) TGFβ1 (10 ng/ml) did not affect microglial HLA-DP, DQ, DR expression alone, or when enhanced by IFNy treatment (D). E) M-CSF (25 ng/ml) reduced basal HLA-DP, DQ, DR expression in microglia and also decreased IFNy-enhanced HLA-DP, DQ, DR expression in microglia (F). Scale bar = 100 µm. G) A significant increase in percentage of HLA-positive microglia is found with IFNy treatment. No change in microglial HLA-DP, DQ, DR expression is seen for TGFβ1 treatment, but M-CSF significantly reduces microglial HLA-DP, DQ, DR protein expression (N = 12). H) The number of microglia per image, as measured by PU.1-immunopositive cells, is significantly increased by IFNy and M-CSF. However, TGFβ1 significantly reduces microglial cell number (N = 12).CC BY · PubMed Central
Figure 2 IFNy produces a change in microglia morphology to a more rounded, less elongated form. A) Adult human microglia immunolabelled with the cell surface marker CD45 have a heterogeneous morphology in basal conditions without any treatment. B) IFNy (1 ng/ml, 96 h) resulted in microglia with a rounder morphology (arrows). Insets in A) and B) show representative morphology of cells. Scale bar = 100 µm. C) Quantification of the ‘rounding’ effect using Metamorph Elliptical Form Factor (a measure of elongation) image analysis demonstrates a significant shift in microglia shape following IFNy treatment to a more rounded and less elongated form (N = 12).
Figure 2 IFNy produces a change in microglia morphology to a more rounded, less elongated form. A) Adult human microglia immunolabelled with the cell surface marker CD45 have a heterogeneous morphology in basal conditions without any treatment. B) IFNy (1 ng/ml, 96 h) resulted in microglia with a rounder morphology (arrows). Insets in A) and B) show representative morphology of cells. Scale bar = 100 µm. C) Quantification of the ‘rounding’ effect using Metamorph Elliptical Form Factor (a measure of elongation) image analysis demonstrates a significant shift in microglia shape following IFNy treatment to a more rounded and less elongated form (N = 12).CC BY · PubMed Central
Figure 3 Astrocytic expression of HLA-DP, DQ, DR is increased by IFNy, and not changed by TGFβ1 or M-CSF. A) Adult human GFAP +ve astrocytes (red) express variable levels of HLA-DP, DQ, DR (green) in basal conditions without any treatment. B) IFNy (1 ng/ml, 96 h) increased astroglial expression of HLA-DP, DQ, DR. C) TGFβ1 (10 ng/ml) did not affect astrocyte HLA-DP, DQ, DR expression alone, or when enhanced by IFNy treatment (D). E) M-CSF (25 ng/ml) also did not affect basal HLA-DP, DQ, DR expression in astrocytes or IFNy-enhanced HLA-DP, DQ, DR expression in astrocytes (F). Insets show close-up examples of astrocytes indicated by arrows. Scale bar = 100 µm. G) A significant increase in percentage of HLA-DP, DQ, DR-immunopositive astrocytes is found with IFNy treatment. Neither TGFβ1 nor M-CSF significantly affect astrocyte HLA-DP, DQ, DR protein expression (N = 12). H) Quantification of GFAP-immunopositive astrocyte cell number (per well) following treatment with IFNy, TGFβ1 or M-CSF does not result in any significant differences compared to vehicle-treated cells (N = 12).
Figure 3 Astrocytic expression of HLA-DP, DQ, DR is increased by IFNy, and not changed by TGFβ1 or M-CSF. A) Adult human GFAP +ve astrocytes (red) express variable levels of HLA-DP, DQ, DR (green) in basal conditions without any treatment. B) IFNy (1 ng/ml, 96 h) increased astroglial expression of HLA-DP, DQ, DR. C) TGFβ1 (10 ng/ml) did not affect astrocyte HLA-DP, DQ, DR expression alone, or when enhanced by IFNy treatment (D). E) M-CSF (25 ng/ml) also did not affect basal HLA-DP, DQ, DR expression in astrocytes or IFNy-enhanced HLA-DP, DQ, DR expression in astrocytes (F). Insets show close-up examples of astrocytes indicated by arrows. Scale bar = 100 µm. G) A significant increase in percentage of HLA-DP, DQ, DR-immunopositive astrocytes is found with IFNy treatment. Neither TGFβ1 nor M-CSF significantly affect astrocyte HLA-DP, DQ, DR protein expression (N = 12). H) Quantification of GFAP-immunopositive astrocyte cell number (per well) following treatment with IFNy, TGFβ1 or M-CSF does not result in any significant differences compared to vehicle-treated cells (N = 12).CC BY · PubMed Central
Figure 4 Brain-derived pericytes do not express HLA-DP, DQ, DR protein under basal conditions but it is induced by IFNy in a concentration-dependent manner. A) In normal culture conditions of DMEM/F12 +10% FBS +1% PSG brain pericytes do not express HLA-DP, DQ, DR protein. However, IFNy (0.1–10 ng/ml, 96 h) induced a concentration-dependent increase in HLA-DP, DQ, DR expression (B-D). Microglia and astrocytes are not present in cultures after 3–4 passages, producing a culture of pericytes only. Scale bar = 50 µm.
Figure 4 Brain-derived pericytes do not express HLA-DP, DQ, DR protein under basal conditions but it is induced by IFNy in a concentration-dependent manner. A) In normal culture conditions of DMEM/F12 +10% FBS +1% PSG brain pericytes do not express HLA-DP, DQ, DR protein. However, IFNy (0.1–10 ng/ml, 96 h) induced a concentration-dependent increase in HLA-DP, DQ, DR expression (B-D). Microglia and astrocytes are not present in cultures after 3–4 passages, producing a culture of pericytes only. Scale bar = 50 µm.CC BY · PubMed Central
Figure 5 IFNy-induced expression of HLA-DP, DQ, DR in brain-derived pericytes is inhibited by TGFβ1 but not by M-CSF. A) Vehicle-treated pericytes (Hoechst-labelled nuclei) do not express HLA-DP, DQ, DR protein. B) IFNy induces a major up-regulation of HLA-DP, DQ, DR protein (green) in brain pericytes. C) TGFβ1 treatment alone does not induce expression of HLA-DP, DQ, DR in these cells. However, TGFβ1 completely inhibits the IFNy-stimulated increase in HLA-DP, DQ, DR (D). M-CSF affects neither basal (E) nor IFNy-induced (F) HLA-DP, DQ, DR expression in brain pericytes. Scale bar = 100 µm. G) HLA-DP, DQ, DR is induced by treatment with IFNy, and inhibited by simultaneous exposure to TGFβ1 but not M-CSF (N = 12). H) Pericyte cell number (per well) is not influenced by IFNy or M-CSF but is significantly decreased by TGFβ1 (N = 12).
Figure 5 IFNy-induced expression of HLA-DP, DQ, DR in brain-derived pericytes is inhibited by TGFβ1 but not by M-CSF. A) Vehicle-treated pericytes (Hoechst-labelled nuclei) do not express HLA-DP, DQ, DR protein. B) IFNy induces a major up-regulation of HLA-DP, DQ, DR protein (green) in brain pericytes. C) TGFβ1 treatment alone does not induce expression of HLA-DP, DQ, DR in these cells. However, TGFβ1 completely inhibits the IFNy-stimulated increase in HLA-DP, DQ, DR (D). M-CSF affects neither basal (E) nor IFNy-induced (F) HLA-DP, DQ, DR expression in brain pericytes. Scale bar = 100 µm. G) HLA-DP, DQ, DR is induced by treatment with IFNy, and inhibited by simultaneous exposure to TGFβ1 but not M-CSF (N = 12). H) Pericyte cell number (per well) is not influenced by IFNy or M-CSF but is significantly decreased by TGFβ1 (N = 12).CC BY · PubMed Central
Figure 6 IFNy-induced expression of HLA-DP, DQ, DR in meningeal fibroblasts is completely blocked by TGFβ1. A) In vehicle-treated leptomeningeal explant cultures only leptomeningeal/perivascular macrophages express HLA-DP, DQ, DR (indicated by arrows). B) IFNy increases intensity of HLA expression on macrophage cells and greatly induces HLA expression in meningeal fibroblasts. C) TGFβ1 has no effect on basal leptomeningeal/perivascular macrophage or meningeal fibroblast HLA expression. D) However, TGFβ1 completely inhibits IFNy-induced meningeal fibroblast HLA expression, without affecting leptomeningeal/perivascular macrophage HLA expression. DAB brightfield images have been inverted for image analysis. Scale bar = 100 µm. E) Quantification of HLA expression shows a massive increase in HLA expression in leptomeningeal explant cultures with IFNy but not with TGFβ1 + IFNy (N = 12).
Figure 6 IFNy-induced expression of HLA-DP, DQ, DR in meningeal fibroblasts is completely blocked by TGFβ1. A) In vehicle-treated leptomeningeal explant cultures only leptomeningeal/perivascular macrophages express HLA-DP, DQ, DR (indicated by arrows). B) IFNy increases intensity of HLA expression on macrophage cells and greatly induces HLA expression in meningeal fibroblasts. C) TGFβ1 has no effect on basal leptomeningeal/perivascular macrophage or meningeal fibroblast HLA expression. D) However, TGFβ1 completely inhibits IFNy-induced meningeal fibroblast HLA expression, without affecting leptomeningeal/perivascular macrophage HLA expression. DAB brightfield images have been inverted for image analysis. Scale bar = 100 µm. E) Quantification of HLA expression shows a massive increase in HLA expression in leptomeningeal explant cultures with IFNy but not with TGFβ1 + IFNy (N = 12).CC BY · PubMed Central
Figure 7 IFNy increases pro-inflammatory cytokine and chemokine release from adult human mixed glial cultures and brain-derived pericytes. Here each data point indicates an individual case (n = 3). Control and IFNy-treated samples from the same case are indicated by connecting lines. A) IL-6 secretion is slightly, but not significantly, increased by IFNy treatment of mixed glia (microglia, astrocytes and brain-derived pericytes). B) MCP-1 production is significantly increased by IFNy in mixed glia cultures. C) Adult human mixed glia produce a low basal level of IP-10 which is markedly increased by IFNy. D) Relatively low concentrations of IL-6 production by pericytes are not changed by IFNy. E) Pericyte cell cultures produce comparable levels of MCP-1 to mixed glial cultures when stimulated with IFNy. F) Pericytes release IP-10 upon IFNy stimulation only.
Figure 7 IFNy increases pro-inflammatory cytokine and chemokine release from adult human mixed glial cultures and brain-derived pericytes. Here each data point indicates an individual case (n = 3). Control and IFNy-treated samples from the same case are indicated by connecting lines. A) IL-6 secretion is slightly, but not significantly, increased by IFNy treatment of mixed glia (microglia, astrocytes and brain-derived pericytes). B) MCP-1 production is significantly increased by IFNy in mixed glia cultures. C) Adult human mixed glia produce a low basal level of IP-10 which is markedly increased by IFNy. D) Relatively low concentrations of IL-6 production by pericytes are not changed by IFNy. E) Pericyte cell cultures produce comparable levels of MCP-1 to mixed glial cultures when stimulated with IFNy. F) Pericytes release IP-10 upon IFNy stimulation only.CC BY · PubMed Central
Figure 8 IP-10 is expressed by microglia and astrocytes in primary adult human mixed glial cultures. A) Following IFNy treatment (1 ng/ml, 96 h) IP-10 expression (green) is co-localised with CD45-immunopositive microglia (red). All nuclei are labelled with Hoechst (blue). Hoechst, IP-10 and CD45 and overlaid in the far right image. B) GFAP-immunopositive astrocytes (red) express IP-10 following IFNy treatment. Hoechst, IP-10 and GFAP are overlaid in the far right image. Scale bar = 100 µm. Arrows indicate high levels of IP-10 expression and insets show close-up examples of cells expressing IP-10.
Figure 8 IP-10 is expressed by microglia and astrocytes in primary adult human mixed glial cultures. A) Following IFNy treatment (1 ng/ml, 96 h) IP-10 expression (green) is co-localised with CD45-immunopositive microglia (red). All nuclei are labelled with Hoechst (blue). Hoechst, IP-10 and CD45 and overlaid in the far right image. B) GFAP-immunopositive astrocytes (red) express IP-10 following IFNy treatment. Hoechst, IP-10 and GFAP are overlaid in the far right image. Scale bar = 100 µm. Arrows indicate high levels of IP-10 expression and insets show close-up examples of cells expressing IP-10.CC BY · PubMed Central
Figure 9 IFNy induces IP-10 expression in pericytes and is not affected by TGFβ1 or M-CSF. Following IFNy treatment, IP-10 expression is significantly increased in pericytes from basal levels. Simultaneous treatment with either TGFβ1 or M-CSF does not affect the levels of IP-10 expression induced by IFNy (N = 12).
Figure 9 IFNy induces IP-10 expression in pericytes and is not affected by TGFβ1 or M-CSF. Following IFNy treatment, IP-10 expression is significantly increased in pericytes from basal levels. Simultaneous treatment with either TGFβ1 or M-CSF does not affect the levels of IP-10 expression induced by IFNy (N = 12).CC BY · PubMed Central
Figure 10 Differential regulation of HLA and IP-10 in adult human microglia, astrocytes, brain pericytes and meningeal fibroblasts by IFNy, TGFβ1 and M-CSF. The T cell pro-inflammatory cytokine IFNy upregulates HLA and IP-10 protein expression in adult human brain glial cells, pericytes and meningeal fibroblasts. Microglial HLA was increased by IFNγ (1 ng/ml for 96 h). M-CSF (25 ng/ml), but not TGFβ1 (10 ng/ml), was found to decrease microglial HLA expression. Astrocytic expression of HLA was also increased by IFNγ, and not modulated by TGFβ1 or M-CSF. Brain pericytes and meningeal fibroblasts do not basally express HLA but have a marked induction on exposure to IFNγ, which was blocked by TGFβ1. IFNγ increased adult human microglia, astrocyte and pericyte expression and release of pro-inflammatory cytokines and chemokines, particularly IP-10. IP-10 may be involved in leukocyte trafficking into the CNS.
Figure 10 Differential regulation of HLA and IP-10 in adult human microglia, astrocytes, brain pericytes and meningeal fibroblasts by IFNy, TGFβ1 and M-CSF. The T cell pro-inflammatory cytokine IFNy upregulates HLA and IP-10 protein expression in adult human brain glial cells, pericytes and meningeal fibroblasts. Microglial HLA was increased by IFNγ (1 ng/ml for 96 h). M-CSF (25 ng/ml), but not TGFβ1 (10 ng/ml), was found to decrease microglial HLA expression. Astrocytic expression of HLA was also increased by IFNγ, and not modulated by TGFβ1 or M-CSF. Brain pericytes and meningeal fibroblasts do not basally express HLA but have a marked induction on exposure to IFNγ, which was blocked by TGFβ1. IFNγ increased adult human microglia, astrocyte and pericyte expression and release of pro-inflammatory cytokines and chemokines, particularly IP-10. IP-10 may be involved in leukocyte trafficking into the CNS.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 91 references

Cited by

Metadata

Authors
Smith, A. M., Graham, E. S., Feng, S. X., Oldfield, R. L., Bergin, P. M., Mee, E. W., Faull, R. L. M., Curtis, M. A., & Dragunow, M.
Affiliations
University of Auckland (NZ)
Corresponding author
Dragunow, Mike
Venue
PLoS ONE
Published
2013-12-05
Volume
8
Issue
12
Pages
e80463
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2031939272
Cited by
38
References
90
Citations by year
2025: 3 · 2024: 2 · 2023: 2 · 2022: 3 · 2021: 7 · 2020: 3 · 2019: 1 · 2018: 3 · 2017: 1 · 2016: 7 · 2015: 4 · 2014: 2
FWCI
2.43
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Tertiary Education Commission
  • Neurological Foundation of New Zealand
  • Health Research Council of New Zealand
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
  • Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Keywords
interferon-gamma, TGF-β1, macrophage colony-stimulating factor, HLA expression, CXCL10, microglia, astrocytes, pericytes, meningeal fibroblasts, glial activation, neuroinflammation, cytokine regulation, human brain cells
MeSH terms
Adult, Astrocytes, Fibroblasts, Gene Expression Regulation, HLA-D Antigens, Humans, Interferon-gamma, Meninges, Neuroglia, Macrophage Colony-Stimulating Factor, Chemokines, Pericytes, Transforming Growth Factor beta1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.